Transcription of Guidance for Industry - CDSCO
{{id}} {{{paragraph}}}
Submission of Clinical Trial Application for Evaluating Safety and Efficacy Requirements for permission of New Drugs Approval Post approval changes in biological products: Quality safety and Efficacy Documents Preparation of the Quality Information for drug Submission for New drug Approval: Biotechnological/Biological Products Guidance for Industry central Drugs Standard Control Organization Ministry of Health | Govt. of India Guidance for Industry central Drugs Standard Control Organization Page 2 Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy (General considerations for conducting Clinical Trial as per Drugs and Cosmetics Act 1940 and Rules 1945) Document No. - CT/71108 Version Guidance for Industry central Drugs Standard Control Organization Page 3 OBJECTIVE This Guidance has been developed in conformity with Drugs and Cosmetics and Rules there under and GCP Guidelines of India for the purpose of submission of Clinical Trial application.
Central Drugs Standard Control Organization Page 4 1940 and Rules 1945. As the Form 44 is an application for grant of permission to import or manufacture a new drug or to undertake Clinical Trial, the Central Drugs Standard Control Organization prescribes information to be submitted
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}